12 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... indicate preferred treatment ... corticosteroid; FEV1 ... #Management #Pulmonary ... #LABA #ICS #Guidelines
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
Asthma (GINA) treatment ... receptor antagonists; LABA ... immunotherapy; FEV1 ... #GINA #Asthma #Management ... #Stepwise #Pulmonary
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Chronic Obstructive Pulmonary ... assessment test; FEV1 ... corticosteroid; LABA ... #Algorithm #Management ... #Pulmonary #LABA
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
- No specific lab ... , Pulmonary lymphoma ... Treatment: • ... #COP #BOOP #pulmonary ... ILD #diagnosis #management
Community Acquired Pneumonia (CAP) - Diagnosis and Management

Pneumonia Signs/Symptoms:
 • Confusion/disorientation (LR + 1.9)
 • Cough
Diagnosis and Management ... resuscitation Labs ... procalcitonin level Treatment ... CAP #Diagnosis #Management ... #treatment #Pulmonary
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Triggers: ATRA treatment ... Diagnosis: • Labs ... Imaging: CXR- pulmonary ... sepsis), PE, DAH, CHF ... APML #diagnosis #management
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
starting amiodarone treatment ... - Pulmonary ... Labs: • Nonspecific ... macrophages Treatment ... #diagnosis #management
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... is vital while lab ... & Dry) is the treatment ... differential #algorithm #management ... #heartfailure #chf
Cryptogenic Organizing Pneumonia - Illness Script

PATHOPHYSIOLOGY: Unknown trigger, reversible inflammatory/fibroproliferative process. Polypoid fibroblastic aggregates that plug
Cryptogenic Organizing Pneumonia ... identified (autoimmune, meds ... , neoplastic) TREATMENT ... #diagnosis #management ... #pulmonary
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
murmur 3/6) - Pulmonary ... disease b) CHF ... days before Pulmonary ... Determine if any labs ... medical and surgical management